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Abstract We report on the case of a 60-year-old woman
with complaints of fatigue, coughing, anorexia, atypical
chest pain, recurrent fever, and also ear pain and hearing
loss. A test for anti-neutrophil cytoplasmic antibody
(ANCA) was myeloperoxidase positive with p-ANCA
specificity. Laboratory acute phase parameters were in-
creased. A 2-deoxy-2-[
18F]fluoro-D-glucose positron emis-
sion tomography/computed tomography investigation
showed pathological uptake in the aorta ascendens, with
no other involvement of the large vessels. After therapy
with methylprednisolon intravenously and later prednisolon
orally with methothrexate, her general condition and
hearing loss improved both subjectively and objectively.
“Atypical” Cogan’s syndrome was diagnosed on the basis
of sensorineural deafness with improvement on steroids and
large-vessel vasculitis of the aortic arch.
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Introduction
The association of nonsyphilitic interstitial keratitis and
audiovestibular involvement was first reported in 1934 by
Mogan and Baumgartner. Their description was extended
several years later by Cogan [1].
In “typical” Cogan’s syndrome, the presence of interstitial
keratitis is necessary, the term “atypical” Cogan’s syndrome
is used when other types of inflammatory eye disease,
including conjunctivitis, uveitis, scleritis, and choroiditis are
associated with the vestibuloauditory abnormalities [2]. In
many cases, the symptomatology is not only restricted to
the eyes and the ears but also other organs, thus resembling
systemic vasculitis in one third of the patients. The most
common symptoms are cardiovascular, musculoskeletal,
neurological, gastrointestinal, and mucocutaneous [3].
Positron emission tomography (PET) with 2-deoxy-2-
[
18F]fluoro-D-glucose (FDG) is becoming increasingly
important in diagnosis, staging, and therapy monitoring in
clinical oncology and has recently been used in the
diagnosis of infectious diseases with elevated intracellular
glucose metabolism. Activated inflammatory cells have
been shown to overexpress glucose transporters and to
accumulate increased amounts of glucose and structurally
related substances such as F18-FDG [4, 5].
Therefore FDG-PET is also introduced as a diagnostic
means to assess involvement in large vessel vasculitis [6].
In this report, we report the use of FDG-PET/computed
tomography (CT) scanning in the diagnosis of Cogan’s
syndrome.
Case report
A 60-year-old Caucasian woman was admitted to the
hospital with a 4-month history of excessive fatigue,
coughing, anorexia and weight loss, night sweats, and
atypical chest pain. She also experienced short periods of
fever. She experienced headaches and ear pain and hearing
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sometimes dizzy. No blurred vision complaints or eye
problems were noted. She was not known with any allergies.
For her hypothyroidism (multinodular goiter), she used
Thyrax (L-thyroxine)150 mcg once a day. She did not
smoke and consumed alcohol only moderately.
The family history revealed a daughter with systemic
lupus erythematosus.
Physical examination revealed a pulse of 104, and
bloodpressure was 125/85 mmHg and the temperature
37.1°C. Heart sounds were normal, and the lungs were
clear. The outer ears were normal. No lymphadenopathy
was detected and no scalp tenderness or decreased pulsation
at the temporal arteries was noted.
Laboratory tests revealed an erythrocyte sedimentation
rate (ESR) of 51 mm/h and C-reactive protein (CRP) of
53 mg/L. Test for rheumatoid factor was 42 kU/L (<10),
and tests for antinuclear facor and double-stranded DNA
antibodies were negative.
A test for anti-neutrophil cytoplasmic antibody (ANCA)
appeared to be myeloperoxidase positive with p-ANCA
specificity.
Serum electrolytes and creatinine were normal. Her
differential blood count, alkaline phosphatase, and trans-
aminases were normal. The urine gave a negative test for
protein, and the sediment contained no white cells, red cells,
or casts in the urine.
Initially arteritis temporalis was suspected, but Doppler
ultrasonography of the temporal arteries showed no abnor-
malities. A chest X-ray revealed no interstitial or focal
abnormalities. Subsequently, a PET/CT was performed,
which showed pathological uptake in the wall of the aortic
arch. More intens pathological uptake was seen at the
beginning of the aorta descendens in the lateral wall, most
likely a sign of perivascular inflammation. Maximum
standard uptake value (SUV max) measured 11.9. No other
involvement of large vessels was noted (Fig. 1). A magnetic
resonance imaging (MRI) scan of the cerebrum showed
abnormalities suspicious for bilateral mastoiditis, possibly
as a consequence of bilateral otitis media.
After placing inner ear tubes, her hearing loss improved
only little. Culture of the ear secretion was negative for
pathogenic microorganisms. Audiograms confirmed senso-
rineural hearing loss, particularly in the left ear.
Investigation of the eyes revealed no abnormalities,
especially no keratitis.
Therapy was started with three cycles of 1,000 mg
methylprednisolon intravenously and later 60 mg prednisolon
daily orally. Her general condition and hearing loss improved
subjectively. Audiograms 6 weeks later showed also objective
improvement of hearing. A control CTscan showed improve-
ment of the abnormalites in both mastoid regions.
As a consequence of the high doses of steroids,
risedronate and calcium supplementation were started, and
also methothrexate was added for the reason of its steroid-
sparing effect. “Atypical” Cogan’s syndrome was diagnosed
on the basis of sensorineural deafness with improvement on
steroids and large-vessel vasculitis of the aortic arch.
A follow-up PET/CT investigation 3 weeks later showed
clearly decreased uptake in the aortic arch, especially a
Fig. 1 a Transverse fused PET/
CT slice showing pathological
uptake in the wall of the aortic
arch and particularly in the later-
al wall and perivascular space
adjacent to the truncus pulmona-
lis (SUV max 11.9). b Follow-up
PET/CT 3 weeks later, after
treatment with methylpredniso-
lon i.v. and prednisolon orally,
showing clearly decreased up-
take in the aortic arch (SUV
max 4.3). c Second follow-up
PET/CT 6 months later, while
patient was in a stable condition
with methotrexate and low-dose
prednisone. Again, high patho-
logical uptake in the aortic arch
with higher intensity in the
lateral wall and perivascular
space adjacent to the truncus
pulmonalis (SUV max 12.9)
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lateral wall, compared to the first PET/CT. The SUV max
was calculated 4.3. ESR and CRP after 2 weeks of therapy
were, respectively, 11 mm/h and <2 mg/L. White cell count
was still elevated (16.9.10
9 L).
Six months later, she was in a stable condition with
methotrexate and low-dose prednisone, and her ESR, CRP,
and white cell count were now, respectively, 24 mm/h,
14 mg/L, and 13.7.10
9 L.
A third PET/CT showed higher pathological activity,
compared to the first PET/CT, in the wall of the aortic arch
and in the perivascular space adjacent to the truncus
pulmonalis (the SUV max was12.9 compared to the SUV
max of 11.9 of the first pretherapy PET/CT investigation).
Consequently, the dose of methothrexate and prednisone
were both increased to 20 mg/day.
Discussion
The etiology of Cogan’s syndrome is unknown; a minority
of patients have rheumatoid factor, antinuclear bodies, and
diminished complement levels. Histology of biopsies shows
often vasculitis and perivascular inflammation. Giant cells
may be present [7]. Specific involvement of large arteries
has been reported in Cogan’s syndrome [8]. Aortitis in
Cogan’s syndrome is indistinguishable from Takayasu’s
arteritis. Cardiac involvement during the course of Cogan’s
syndrome is, above all, aortic insufficiency. It is a severe
complication that may require valve replacement, without
which left ventricle involvement insufficiency develops,
which can be fatal [9, 10].
Standard diagnostic modalities such as biopsy, angiogra-
phy, ultrasound, and MRI are commonly unable to demon-
strate the full extent of vascular involvement in large-vessel
vasculitis. PET investigations might play an important role
here as large-vessel F18-FDG uptake is positively correlated
withthelevelofacute phasereactantmarkersinpatientswith
large vessel vasculitis. In a study of 18 patients with
Takayasu’s arteritis, the F18-FDG-PETexamination showed
a sensitivity of 92% and a specificity of 100% [11].
This is, to the best of our knowledge, the first report of
Cogan’s syndrome diagnosed by the use of FDG-PET/CT
scanning. This case report is also supportive in the
hypothesis that with PET, the inflammatory activity of
large-vessel vasculitis is more accurately assessed compared
to laboratory acute phase parameters [12]. The CT compo-
nent of PET/CT is useful in the precise anatomical
localization of the PET abnormalities and may provide
information about changes in the wall structure or luminal
flow [13].
The conclusion seems justified that F18-FDG-PET/CT is
helpful in risk assessment of large-vessel vasculitis, as it
provides intrinsically fused morphologic and functional
data in a single examination.
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